Multicomponent Nucleic Acid Probes for In Situ Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing oligonucleotide probe-based assay methods for in situ nucleic acid analysis suffer from low sensitivity, specificity, and detection efficiency, requiring laborious optimization.

Innovation Solution

A method involving the formation of a hybridization complex with a first nucleic acid molecule, a second nucleic acid molecule, a splint, and a target nucleic acid, where the complex includes specific sequences and regions that differ in duplex stability, allowing for efficient detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If oligonucleotide probe-based assay methods are used for in situ nucleic acid analysis, then the analysis can be performed, but the sensitivity, specificity, and detection efficiency are low

Engineering Contradiction:
Improvedetection efficiencyVSAvoidprobe structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The probe is divided into multiple functional components: a first nucleic acid molecule with a first hybridizing region and first nonhybridizing region, a second nucleic acid molecule with a second hybridizing region and second nonhybridizing region, and a splint molecule. This segmentation allows each component to perform its specific function independently, improving overall detection efficiency while maintaining manageable complexity through modular design.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The splint molecule acts as an intermediary that hybridizes to both the first and second nonhybridizing regions, coupling the two probe molecules together. This intermediary element enables the formation of a stable hybridization complex that enhances detection efficiency without requiring the probes to directly interact with each other, simplifying the overall probe structure design.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If oligonucleotide probe-based assay methods are used for in situ nucleic acid analysis, then the analysis can be performed, but laborious optimization is required

Engineering Contradiction:
Improveoptimization effortVSAvoiddetection accuracy
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The probe design incorporates specific parameter characteristics: the first and second hybridizing regions have lengths between 1-50 nucleotides, the nonhybridizing regions have specific sequences that bind to the splint, and the splint has complementary sequences to both nonhybridizing regions. These predetermined parameter ranges and sequence characteristics reduce the need for laborious optimization while ensuring reliable detection accuracy.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The probe molecules and splint are designed with pre-determined hybridization and coupling characteristics before use. The first and second nucleic acid molecules are configured with specific hybridizing regions that will bind to target sequences and nonhybridizing regions that will couple via the splint. This preliminary design of functional characteristics eliminates the need for extensive optimization during actual analysis.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If the first and second nucleic acid molecules are coupled to form a circular probe, then the detection can be enhanced, but the structural complexity increases

Engineering Contradiction:
Improvedetection efficiencyVSAvoidprobe structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The splint molecule serves as an intermediary that couples the first and second nucleic acid molecules together through hybridization to its nonhybridizing regions. This intermediary coupling mechanism forms a circular probe structure that enhances detection efficiency while maintaining structural clarity, as the splint provides a defined connection point between the two probe molecules without requiring complex direct interactions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The first and second nucleic acid molecules are merged into a circular probe structure through coupling of their nonhybridizing regions via the splint. This merging combines the functional capabilities of both probe molecules into a single integrated detection unit, enhancing detection efficiency while the modular nature of the components keeps the structural complexity manageable.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enhances the sensitivity, specificity, and detection efficiency of in situ nucleic acid analysis, reducing the need for extensive optimization and improving the accuracy of biological sample analysis.

Implementation Method 1

the first nucleic acid molecule (e.g., the first probe) comprises, from one end to another: (i) a first nonhybridizing region (e.g., a first splint-hybridizing region) forming a first duplex with the sequence (e.g., the first splint sequence) and (ii) a first hybridizing region (e.g., a first target-hybridizing region) hybridized to the first target sequence

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

the third nucleic acid molecule (e.g., the splint) comprises a sequence (e.g., a first splint sequence) and an additional sequence (e.g., a second splint sequence): the first nucleic acid molecule (e.g., the first probe) comprises, from one end to another: (i) a first nonhybridizing region (e.g., a first splint-hybridizing region) forming a first duplex with the sequence (e.g., the first splint sequence)

Methodology Applied
Scientific EffectDuplex formation:

Data Source

PatentUS12297499B2Multicomponent nucleic acid probes for sample analysis
Publication Date: 2025.05.13 10X GENOMICS INC
  • US12297499B2 patent drawing
  • US12297499B2 patent drawing
  • US12297499B2 patent drawing

AI summary

The present disclosure provides methods, systems, compositions, and kits for analyzing target molecules, including using probes comprising a plurality of components for analyzing target molecules in situ in a sample.